JW Pharmaceutical Corporation (KRX:001060)
South Korea
· Delayed Price · Currency is KRW 32,000
-500 (-1.54%)
Apr 29, 2026, 2:47 PM KST
JW Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 741,750 | 584,933 | 561,695 | 828,523 | 419,688 | 505,678 | Upgrade
|
| Market Cap Growth | 50.73% | 4.14% | -32.20% | 97.41% | -17.00% | -32.85% | Upgrade
|
| Enterprise Value | 735,044 | 571,085 | 600,784 | 959,912 | 491,395 | 649,827 | Upgrade
|
| Last Close Price | 32500.00 | 24967.90 | 23499.20 | 34154.17 | 17093.97 | 20225.75 | Upgrade
|
| PE Ratio | 12.83 | 9.51 | 8.64 | 22.39 | 13.16 | - | Upgrade
|
| PS Ratio | 0.96 | 0.75 | 0.78 | 1.11 | 0.61 | 0.83 | Upgrade
|
| PB Ratio | 2.01 | 1.58 | 1.71 | 3.12 | 1.86 | 2.68 | Upgrade
|
| P/TBV Ratio | 2.08 | 1.64 | 1.76 | 3.29 | 1.84 | 2.68 | Upgrade
|
| P/FCF Ratio | 8.77 | 6.91 | 7.90 | 13.84 | 8.96 | 47.45 | Upgrade
|
| P/OCF Ratio | 7.69 | 6.07 | 7.08 | 9.51 | 7.39 | 27.90 | Upgrade
|
| EV/Sales Ratio | 0.95 | 0.74 | 0.84 | 1.28 | 0.72 | 1.07 | Upgrade
|
| EV/EBITDA Ratio | 6.75 | 5.36 | 5.90 | 8.05 | 6.36 | 13.84 | Upgrade
|
| EV/EBIT Ratio | 8.15 | 6.50 | 7.26 | 9.93 | 8.12 | 21.07 | Upgrade
|
| EV/FCF Ratio | 8.69 | 6.75 | 8.45 | 16.03 | 10.49 | 60.98 | Upgrade
|
| Debt / Equity Ratio | 0.15 | 0.15 | 0.28 | 0.64 | 0.93 | 1.30 | Upgrade
|
| Debt / EBITDA Ratio | 0.51 | 0.51 | 0.90 | 1.43 | 2.71 | 5.22 | Upgrade
|
| Debt / FCF Ratio | 0.65 | 0.65 | 1.29 | 2.84 | 4.47 | 23.00 | Upgrade
|
| Net Debt / Equity Ratio | -0.02 | -0.02 | 0.18 | 0.29 | 0.27 | 0.95 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.06 | -0.06 | 0.58 | 0.64 | 0.77 | 3.82 | Upgrade
|
| Net Debt / FCF Ratio | -0.08 | -0.08 | 0.83 | 1.27 | 1.28 | 16.84 | Upgrade
|
| Asset Turnover | 1.28 | 1.28 | 1.15 | 1.18 | 1.09 | 1.03 | Upgrade
|
| Inventory Turnover | 3.75 | 3.75 | 3.64 | 3.79 | 3.70 | 3.65 | Upgrade
|
| Quick Ratio | 0.86 | 0.86 | 0.82 | 0.90 | 0.80 | 0.79 | Upgrade
|
| Current Ratio | 1.42 | 1.42 | 1.47 | 1.32 | 1.12 | 1.30 | Upgrade
|
| Return on Equity (ROE) | 17.60% | 17.60% | 21.87% | 15.65% | 14.41% | -0.73% | Upgrade
|
| Return on Assets (ROA) | 9.08% | 9.08% | 8.28% | 9.49% | 6.00% | 3.26% | Upgrade
|
| Return on Invested Capital (ROIC) | 17.31% | 16.20% | 17.88% | 21.60% | 12.18% | -0.62% | Upgrade
|
| Return on Capital Employed (ROCE) | 22.20% | 22.20% | 20.90% | 27.00% | 24.40% | 8.80% | Upgrade
|
| Earnings Yield | 8.29% | 10.52% | 11.58% | 4.47% | 7.60% | -0.19% | Upgrade
|
| FCF Yield | 11.41% | 14.47% | 12.65% | 7.23% | 11.16% | 2.11% | Upgrade
|
| Payout Ratio | 17.99% | 17.99% | 14.86% | 23.82% | 23.05% | - | Upgrade
|
| Buyback Yield / Dilution | 1.32% | 1.32% | -3.34% | -2.49% | -0.07% | 0.05% | Upgrade
|
| Total Shareholder Return | 2.72% | 1.32% | -3.34% | -2.49% | -0.07% | 0.05% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.